Dr. Martens plc
DOCMF · OTC
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $433 | – | $463 | $325 |
| % Growth | – | – | 42.6% | – |
| Cost of Goods Sold | $197 | – | $159 | $117 |
| Gross Profit | $236 | – | $304 | $208 |
| % Margin | 54.6% | – | 65.7% | 64% |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $0 | – | $0 | $0 |
| SG&A Expenses | $232 | – | $156 | $223 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $77 | $0 |
| Operating Expenses | $232 | – | $233 | $223 |
| Operating Income | $4 | – | $71 | -$15 |
| % Margin | 1% | – | 15.4% | -4.7% |
| Other Income/Exp. Net | -$19 | – | -$34 | -$14 |
| Pre-Tax Income | -$15 | – | $38 | -$29 |
| Tax Expense | -$1 | – | $12 | -$8 |
| Net Income | -$13 | – | $25 | -$21 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS | -0.014 | – | 0.034 | -0.022 |
| % Growth | – | – | 254.5% | – |
| EPS Diluted | -0.014 | – | 0.034 | -0.022 |
| Weighted Avg Shares Out | 966 | – | 962 | 945 |
| Weighted Avg Shares Out Dil | 966 | – | 964 | 945 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | – | $3 | $0 |
| Interest Expense | $19 | – | $21 | $14 |
| Depreciation & Amortization | $47 | – | $62 | $11 |
| EBITDA | $51 | – | $115 | -$5 |
| % Margin | 11.7% | – | 24.8% | -1.4% |